Will Novavax Stock Jump Another 25% This Year?

In this Motley Fool Live video recorded on Feb. 3, Fool.com contributors Keith Speights and Brian Orelli discuss whether or not Novavax stock can tack on another 25% this year. It came from Novavax, the ticker there is NVAX. Novavax reported 89.3% overall efficacy for its COVID vaccine and these were from results from a late-stage study conducted in the United Kingdom.

Leave a Reply